AIP
EW icon

Ahrens Investment Partners’s Edwards Lifesciences EW Stock Holding History

Ahrens Investment Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$97.3K Buy
+1,176
New +$92.4K 0.05% 220
2022
Q3 		– Sell
-1,176
Closed -$112K – 402
2022
Q2 		$112K Hold
1,176
– – 0.05% 216
2022
Q1 		$138K Hold
1,176
– – 0.04% 225
2021
Q4 		$152K Buy
+1,176
New +$137K 0.07% 225

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ahrens Investment Partners's EW Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Edwards Lifesciences (EW) in Q1 2023: 1,176 shares worth $97.3K. The stake represents 0.05% of the portfolio and ranks #220 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in EW as recently as Q2 2022.

Ahrens Investment Partners first reported a position in EW in Q4 2021 and has held it in 4 quarters since. The position peaked at $152K in Q4 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Ahrens Investment Partners held 1,176 shares of Edwards Lifesciences worth $97.3K as of Q1 2023.
  • Edwards Lifesciences was a new Ahrens Investment Partners position in Q1 2023.
  • Edwards Lifesciences made up 0.05% of Ahrens Investment Partners's portfolio in Q1 2023, its #220 holding.
  • Ahrens Investment Partners first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Edwards Lifesciences position peaked at $152K in Q4 2021.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.